Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Correction: Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 Study.
Correction: Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 Study. Annals of surgical oncology Zager, J. S., Orloff, M., Ferrucci, P. F., Choi, J., Eschelman, D. J., Glazer, E. S., Ejaz, A., Howard, J. H., Richtig, E., Ochsenreither, S., Reddy, S. A., Lowe, M. C., Beasley, G. M., Gesierich, A., Bender, A., Gschnell, M., Dummer, R., Rivoire, M., Arance, A., Fenwick, S. W., Sacco, J. J., Haferkamp, S., Weishaupt, C., John, J., Wheater, M., Ottensmeier, C. H. 2024View details for DOI 10.1245/s10434-024-15886-6
View details for PubMedID 39026142